Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Potassium chloride 0 075 in dextrose 5 and sodium chloride 0 2 in plastic container discount?How much is methadone at the pharmacy?Is there a generic for ingrezza?Brepocitinib synthetic route patent benzyl diazabicyclo?Imitrex generic price?
See the DrugPatentWatch profile for Atomoxetine
Atomoxetine is classified as a non-stimulant medication. It is a selective norepinephrine reuptake inhibitor (SNRI)—meaning it mainly works by blocking the norepinephrine transporter (NET), which increases norepinephrine activity in the brain.
Atomoxetine is considered non-stimulant, unlike stimulant ADHD drugs such as methylphenidate and amphetamines. Because it does not act as a direct stimulant, its onset and side-effect profile can differ from those medications.
Atomoxetine is used to treat attention-deficit/hyperactivity disorder (ADHD). It is also used in some regions for related indications, depending on local regulatory approvals.
Because atomoxetine targets norepinephrine reuptake, it affects attention and impulse control through noradrenergic pathways rather than via dopamine-driven stimulant mechanisms.
No sources provided in the prompt.
Other Questions About Atomoxetine :